About
Oncology & Metabolic Diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (23)
View allTotal Trials
23
As Lead Sponsor
22
As Collaborator
1
Total Enrollment
2,989
By Phase
PHASE3: 2PHASE2: 5PHASE1: 9PHASE1/PHASE2: 6EARLY_PHASE1: 1
By Status
COMPLETED: 15RECRUITING: 3ACTIVE_NOT_RECRUITING: 3NOT_YET_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline23 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07130604Lead Sponsor
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
PHASE3Not yet recruiting
390 participants
Started: Sep 26, 2025 · Completed: Jul 28, 2027
NCT07035041Lead Sponsor
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis
PHASE2Recruiting
120 participants
Started: May 22, 2025 · Completed: Dec 31, 2026
NCT06278350Lead Sponsor
Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis
PHASE2Completed
161 participants
Started: Jan 31, 2024 · Completed: Nov 1, 2024
NCT06233916Lead Sponsor
Mass Balance Study of [14C] D-1553 in Chinese Healthy Adult Male Subjects
PHASE1Completed
8 participants
Started: Dec 8, 2023 · Completed: Jan 10, 2024
NCT06105255Lead Sponsor
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
PHASE1Completed
45 participants
Started: May 24, 2023 · Completed: Feb 2, 2024
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...